The average effective dose of 4-amino-5-(furan-2-yl)-4H-1 ,2,4-triazole-3-thiol in experimental hepatitis
DOI:
https://doi.org/10.14739/2310-1210.2014.2.25445Keywords:
triazole derivatives, experimental hepatitis, average effective dose, probit-analysisAbstract
The work presents the research of the average effective dose of 4-amino-5-(furan-2-yl)-4H-1,2,4-triazole-3-thiol in experimental hepatitis. Recalculations conducted for the human with the sensitivity coefficient, average effective dose for human is 13,87 mg/kg.
References
Stefanov O.V. Doclinicheskiye doslidzhenia likarskikh zahodiv [Preclinic investigation medicines: metodic recomendation]. Kiev, Avicena 2001. 528 p.
Morosov S.Yu. Hepatoprotectors in practic work of clinic doctor. Russky medicinsky zhurnal, 2009; № 11 (1): 25.
Nikitin I.G. Hepatoprotectors: miths and real opportunity. Pharmoteka, 2007., № 12 (147): 14-18.
Polunina T.E., Mayev I.V., Polunina E.V. Hepatologiya dlia practicheskogo vracha [Hepatology for practic doctor]. Moscow, Avtorckaya academiya 2009., 350 p.
Platonov A.G., Ahalaya M.Ya. Dosovaya zavisimost postluchevoy zgibeli. Raschet poluletalnoy dozy LD50 metodom probitanalisa [Dose dependence of the post-radiation death. Calculation sublethal dose LD50 by probit analysis]., Mascow, MGU, 2006., 33 p.
Prozorovskit V.B. Statistic analysis of the results of pharmacological studies., Psikhofarmakologiya biologiya narkologiya, 2007., № 7 (3-4): 2090-2120.
Rybolovlev Yu.R., Rybolovlev R.S. Dosing substances for mammalian constant biological activity. Zhurnal AMN SSSR, 1979., №247 (6): 1513-1516.
Tkach S.M. Effectiveness and safety hepatoprotectors terms of evidence-based medicine., Zdorovye ukrainy, 2009., № 6: 7-10.
Donnelly KL, Smith CI, Schwarzenberg SJ et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non–alcoholic fatty liver disease.// J Clin Invest 2005; 115(5):1343–51.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.